nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—hypertension—type 2 diabetes mellitus	0.429	1	CtDrD
Guanabenz—ADRA2A—type 2 diabetes mellitus	0.147	0.59	CbGaD
Guanabenz—CYP1A2—type 2 diabetes mellitus	0.102	0.41	CbGaD
Guanabenz—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0489	0.271	CbGbCtD
Guanabenz—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0464	0.257	CbGbCtD
Guanabenz—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0323	0.179	CbGbCtD
Guanabenz—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0175	0.0968	CbGbCtD
Guanabenz—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0138	0.0762	CbGbCtD
Guanabenz—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.013	0.0721	CbGbCtD
Guanabenz—CYP1A2—Losartan—type 2 diabetes mellitus	0.00888	0.0491	CbGbCtD
Guanabenz—Guanfacine—ADRA2A—type 2 diabetes mellitus	0.001	0.685	CrCbGaD
Guanabenz—Guanfacine—CYP3A4—type 2 diabetes mellitus	0.00046	0.315	CrCbGaD
Guanabenz—NISCH—islet of Langerhans—type 2 diabetes mellitus	0.000281	0.12	CbGeAlD
Guanabenz—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000271	0.116	CbGeAlD
Guanabenz—NISCH—nephron tubule—type 2 diabetes mellitus	0.000226	0.0964	CbGeAlD
Guanabenz—NISCH—pancreas—type 2 diabetes mellitus	0.000198	0.0842	CbGeAlD
Guanabenz—NISCH—cortex of kidney—type 2 diabetes mellitus	0.000194	0.0825	CbGeAlD
Guanabenz—NISCH—adipose tissue—type 2 diabetes mellitus	0.000179	0.0763	CbGeAlD
Guanabenz—NISCH—liver—type 2 diabetes mellitus	0.000126	0.0535	CbGeAlD
Guanabenz—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000103	0.044	CbGeAlD
Guanabenz—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000102	0.0436	CbGeAlD
Guanabenz—ADRA2C—kidney—type 2 diabetes mellitus	9.09e-05	0.0387	CbGeAlD
Guanabenz—ADRA2C—pancreas—type 2 diabetes mellitus	9.03e-05	0.0384	CbGeAlD
Guanabenz—ADRA2C—cortex of kidney—type 2 diabetes mellitus	8.85e-05	0.0377	CbGeAlD
Guanabenz—ADRA2C—adipose tissue—type 2 diabetes mellitus	8.19e-05	0.0349	CbGeAlD
Guanabenz—ADRA2A—pancreas—type 2 diabetes mellitus	7.2e-05	0.0307	CbGeAlD
Guanabenz—ADRA2A—cortex of kidney—type 2 diabetes mellitus	7.06e-05	0.0301	CbGeAlD
Guanabenz—ADRA2A—adipose tissue—type 2 diabetes mellitus	6.54e-05	0.0278	CbGeAlD
Guanabenz—ADRA2C—liver—type 2 diabetes mellitus	5.74e-05	0.0245	CbGeAlD
Guanabenz—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000511	CcSEcCtD
Guanabenz—Headache—Glimepiride—type 2 diabetes mellitus	5.28e-05	0.00051	CcSEcCtD
Guanabenz—Ill-defined disorder—Losartan—type 2 diabetes mellitus	5.27e-05	0.000509	CcSEcCtD
Guanabenz—Cough—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000509	CcSEcCtD
Guanabenz—Headache—Sitagliptin—type 2 diabetes mellitus	5.26e-05	0.000509	CcSEcCtD
Guanabenz—Anaemia—Losartan—type 2 diabetes mellitus	5.25e-05	0.000508	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.22e-05	0.000505	CcSEcCtD
Guanabenz—Agitation—Losartan—type 2 diabetes mellitus	5.22e-05	0.000505	CcSEcCtD
Guanabenz—Oedema—Metformin—type 2 diabetes mellitus	5.22e-05	0.000505	CcSEcCtD
Guanabenz—Tinnitus—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000504	CcSEcCtD
Guanabenz—Hypertension—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000504	CcSEcCtD
Guanabenz—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.2e-05	0.000503	CcSEcCtD
Guanabenz—Angioedema—Losartan—type 2 diabetes mellitus	5.19e-05	0.000502	CcSEcCtD
Guanabenz—Infection—Metformin—type 2 diabetes mellitus	5.19e-05	0.000501	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.16e-05	0.000499	CcSEcCtD
Guanabenz—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000498	CcSEcCtD
Guanabenz—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.14e-05	0.000497	CcSEcCtD
Guanabenz—Myalgia—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000497	CcSEcCtD
Guanabenz—Chest pain—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000497	CcSEcCtD
Guanabenz—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000497	CcSEcCtD
Guanabenz—Shock—Metformin—type 2 diabetes mellitus	5.14e-05	0.000496	CcSEcCtD
Guanabenz—Malaise—Losartan—type 2 diabetes mellitus	5.12e-05	0.000495	CcSEcCtD
Guanabenz—Anxiety—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000495	CcSEcCtD
Guanabenz—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.12e-05	0.000495	CcSEcCtD
Guanabenz—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.12e-05	0.000495	CcSEcCtD
Guanabenz—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.11e-05	0.000494	CcSEcCtD
Guanabenz—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000494	CcSEcCtD
Guanabenz—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000493	CcSEcCtD
Guanabenz—Syncope—Losartan—type 2 diabetes mellitus	5.1e-05	0.000492	CcSEcCtD
Guanabenz—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000492	CcSEcCtD
Guanabenz—Leukopenia—Losartan—type 2 diabetes mellitus	5.09e-05	0.000492	CcSEcCtD
Guanabenz—Discomfort—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000491	CcSEcCtD
Guanabenz—Skin disorder—Metformin—type 2 diabetes mellitus	5.07e-05	0.00049	CcSEcCtD
Guanabenz—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000489	CcSEcCtD
Guanabenz—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000488	CcSEcCtD
Guanabenz—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000487	CcSEcCtD
Guanabenz—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.03e-05	0.000486	CcSEcCtD
Guanabenz—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000486	CcSEcCtD
Guanabenz—Nausea—Glimepiride—type 2 diabetes mellitus	5.01e-05	0.000484	CcSEcCtD
Guanabenz—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.99e-05	0.000483	CcSEcCtD
Guanabenz—Nausea—Sitagliptin—type 2 diabetes mellitus	4.99e-05	0.000482	CcSEcCtD
Guanabenz—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000482	CcSEcCtD
Guanabenz—Asthenia—Glyburide—type 2 diabetes mellitus	4.99e-05	0.000482	CcSEcCtD
Guanabenz—CYP1A2—liver—type 2 diabetes mellitus	4.98e-05	0.0212	CbGeAlD
Guanabenz—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000482	CcSEcCtD
Guanabenz—Anorexia—Metformin—type 2 diabetes mellitus	4.98e-05	0.000481	CcSEcCtD
Guanabenz—Cough—Losartan—type 2 diabetes mellitus	4.96e-05	0.000479	CcSEcCtD
Guanabenz—Urticaria—Gliclazide—type 2 diabetes mellitus	4.96e-05	0.000479	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.95e-05	0.000478	CcSEcCtD
Guanabenz—Fatigue—Valsartan—type 2 diabetes mellitus	4.94e-05	0.000478	CcSEcCtD
Guanabenz—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.93e-05	0.000477	CcSEcCtD
Guanabenz—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.93e-05	0.000477	CcSEcCtD
Guanabenz—Oedema—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000476	CcSEcCtD
Guanabenz—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.93e-05	0.000476	CcSEcCtD
Guanabenz—Pruritus—Glyburide—type 2 diabetes mellitus	4.92e-05	0.000475	CcSEcCtD
Guanabenz—Constipation—Valsartan—type 2 diabetes mellitus	4.9e-05	0.000474	CcSEcCtD
Guanabenz—Infection—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000473	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.89e-05	0.000473	CcSEcCtD
Guanabenz—Fatigue—Orlistat—type 2 diabetes mellitus	4.88e-05	0.000472	CcSEcCtD
Guanabenz—Hypotension—Metformin—type 2 diabetes mellitus	4.88e-05	0.000472	CcSEcCtD
Guanabenz—Malnutrition—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000471	CcSEcCtD
Guanabenz—Erythema—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000471	CcSEcCtD
Guanabenz—Shock—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000469	CcSEcCtD
Guanabenz—Pain—Orlistat—type 2 diabetes mellitus	4.85e-05	0.000468	CcSEcCtD
Guanabenz—Chest pain—Losartan—type 2 diabetes mellitus	4.84e-05	0.000468	CcSEcCtD
Guanabenz—Myalgia—Losartan—type 2 diabetes mellitus	4.84e-05	0.000468	CcSEcCtD
Guanabenz—Arthralgia—Losartan—type 2 diabetes mellitus	4.84e-05	0.000468	CcSEcCtD
Guanabenz—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.83e-05	0.000467	CcSEcCtD
Guanabenz—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000467	CcSEcCtD
Guanabenz—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000466	CcSEcCtD
Guanabenz—Anxiety—Losartan—type 2 diabetes mellitus	4.82e-05	0.000466	CcSEcCtD
Guanabenz—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000465	CcSEcCtD
Guanabenz—Rash—Bromocriptine—type 2 diabetes mellitus	4.79e-05	0.000463	CcSEcCtD
Guanabenz—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.79e-05	0.000463	CcSEcCtD
Guanabenz—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.79e-05	0.000463	CcSEcCtD
Guanabenz—Tension—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000462	CcSEcCtD
Guanabenz—Discomfort—Losartan—type 2 diabetes mellitus	4.78e-05	0.000462	CcSEcCtD
Guanabenz—Headache—Bromocriptine—type 2 diabetes mellitus	4.76e-05	0.00046	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.76e-05	0.00046	CcSEcCtD
Guanabenz—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.76e-05	0.00046	CcSEcCtD
Guanabenz—Nervousness—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000457	CcSEcCtD
Guanabenz—Dry mouth—Losartan—type 2 diabetes mellitus	4.73e-05	0.000457	CcSEcCtD
Guanabenz—Anorexia—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000454	CcSEcCtD
Guanabenz—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000453	CcSEcCtD
Guanabenz—Paraesthesia—Metformin—type 2 diabetes mellitus	4.69e-05	0.000453	CcSEcCtD
Guanabenz—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000453	CcSEcCtD
Guanabenz—Confusional state—Losartan—type 2 diabetes mellitus	4.68e-05	0.000452	CcSEcCtD
Guanabenz—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000451	CcSEcCtD
Guanabenz—Dyspnoea—Metformin—type 2 diabetes mellitus	4.66e-05	0.00045	CcSEcCtD
Guanabenz—Oedema—Losartan—type 2 diabetes mellitus	4.64e-05	0.000448	CcSEcCtD
Guanabenz—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000448	CcSEcCtD
Guanabenz—Infection—Losartan—type 2 diabetes mellitus	4.61e-05	0.000445	CcSEcCtD
Guanabenz—Hypotension—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000445	CcSEcCtD
Guanabenz—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.6e-05	0.000444	CcSEcCtD
Guanabenz—Dyspepsia—Metformin—type 2 diabetes mellitus	4.6e-05	0.000444	CcSEcCtD
Guanabenz—Shock—Losartan—type 2 diabetes mellitus	4.56e-05	0.000441	CcSEcCtD
Guanabenz—Urticaria—Valsartan—type 2 diabetes mellitus	4.56e-05	0.00044	CcSEcCtD
Guanabenz—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.55e-05	0.00044	CcSEcCtD
Guanabenz—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.54e-05	0.000439	CcSEcCtD
Guanabenz—Decreased appetite—Metformin—type 2 diabetes mellitus	4.54e-05	0.000439	CcSEcCtD
Guanabenz—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.53e-05	0.000438	CcSEcCtD
Guanabenz—Tachycardia—Losartan—type 2 diabetes mellitus	4.53e-05	0.000437	CcSEcCtD
Guanabenz—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000437	CcSEcCtD
Guanabenz—Nausea—Bromocriptine—type 2 diabetes mellitus	4.52e-05	0.000436	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.51e-05	0.000436	CcSEcCtD
Guanabenz—Fatigue—Metformin—type 2 diabetes mellitus	4.5e-05	0.000435	CcSEcCtD
Guanabenz—Urticaria—Orlistat—type 2 diabetes mellitus	4.5e-05	0.000435	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000434	CcSEcCtD
Guanabenz—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000433	CcSEcCtD
Guanabenz—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000433	CcSEcCtD
Guanabenz—Asthenia—Gliclazide—type 2 diabetes mellitus	4.48e-05	0.000433	CcSEcCtD
Guanabenz—Agitation—Ramipril—type 2 diabetes mellitus	4.48e-05	0.000433	CcSEcCtD
Guanabenz—Constipation—Metformin—type 2 diabetes mellitus	4.47e-05	0.000432	CcSEcCtD
Guanabenz—Angioedema—Ramipril—type 2 diabetes mellitus	4.45e-05	0.00043	CcSEcCtD
Guanabenz—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000428	CcSEcCtD
Guanabenz—Anorexia—Losartan—type 2 diabetes mellitus	4.42e-05	0.000427	CcSEcCtD
Guanabenz—Vomiting—Glyburide—type 2 diabetes mellitus	4.42e-05	0.000427	CcSEcCtD
Guanabenz—Pruritus—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000427	CcSEcCtD
Guanabenz—Malaise—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000425	CcSEcCtD
Guanabenz—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000425	CcSEcCtD
Guanabenz—Rash—Glyburide—type 2 diabetes mellitus	4.38e-05	0.000424	CcSEcCtD
Guanabenz—Dermatitis—Glyburide—type 2 diabetes mellitus	4.38e-05	0.000423	CcSEcCtD
Guanabenz—Syncope—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000422	CcSEcCtD
Guanabenz—Leukopenia—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000421	CcSEcCtD
Guanabenz—Headache—Glyburide—type 2 diabetes mellitus	4.35e-05	0.000421	CcSEcCtD
Guanabenz—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000419	CcSEcCtD
Guanabenz—Hypotension—Losartan—type 2 diabetes mellitus	4.33e-05	0.000419	CcSEcCtD
Guanabenz—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.3e-05	0.000416	CcSEcCtD
Guanabenz—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000414	CcSEcCtD
Guanabenz—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000414	CcSEcCtD
Guanabenz—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.000413	CcSEcCtD
Guanabenz—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.27e-05	0.000413	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000411	CcSEcCtD
Guanabenz—Cough—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000411	CcSEcCtD
Guanabenz—Fatigue—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000411	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.22e-05	0.000408	CcSEcCtD
Guanabenz—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.22e-05	0.000408	CcSEcCtD
Guanabenz—Pain—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000407	CcSEcCtD
Guanabenz—Constipation—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000407	CcSEcCtD
Guanabenz—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000403	CcSEcCtD
Guanabenz—Paraesthesia—Losartan—type 2 diabetes mellitus	4.16e-05	0.000402	CcSEcCtD
Guanabenz—Urticaria—Metformin—type 2 diabetes mellitus	4.15e-05	0.000401	CcSEcCtD
Guanabenz—Arthralgia—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000401	CcSEcCtD
Guanabenz—Chest pain—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000401	CcSEcCtD
Guanabenz—Myalgia—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000401	CcSEcCtD
Guanabenz—Dyspnoea—Losartan—type 2 diabetes mellitus	4.13e-05	0.0004	CcSEcCtD
Guanabenz—Anxiety—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000399	CcSEcCtD
Guanabenz—Nausea—Glyburide—type 2 diabetes mellitus	4.13e-05	0.000399	CcSEcCtD
Guanabenz—Abdominal pain—Metformin—type 2 diabetes mellitus	4.13e-05	0.000399	CcSEcCtD
Guanabenz—Dizziness—Gliclazide—type 2 diabetes mellitus	4.13e-05	0.000399	CcSEcCtD
Guanabenz—Asthenia—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000398	CcSEcCtD
Guanabenz—Discomfort—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000396	CcSEcCtD
Guanabenz—Dyspepsia—Losartan—type 2 diabetes mellitus	4.08e-05	0.000394	CcSEcCtD
Guanabenz—Asthenia—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000393	CcSEcCtD
Guanabenz—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000392	CcSEcCtD
Guanabenz—Pruritus—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000392	CcSEcCtD
Guanabenz—Dry mouth—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000392	CcSEcCtD
Guanabenz—Decreased appetite—Losartan—type 2 diabetes mellitus	4.03e-05	0.00039	CcSEcCtD
Guanabenz—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000389	CcSEcCtD
Guanabenz—Confusional state—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000387	CcSEcCtD
Guanabenz—Pruritus—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000387	CcSEcCtD
Guanabenz—Fatigue—Losartan—type 2 diabetes mellitus	4e-05	0.000386	CcSEcCtD
Guanabenz—Oedema—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000384	CcSEcCtD
Guanabenz—Vomiting—Gliclazide—type 2 diabetes mellitus	3.97e-05	0.000383	CcSEcCtD
Guanabenz—Pain—Losartan—type 2 diabetes mellitus	3.97e-05	0.000383	CcSEcCtD
Guanabenz—Constipation—Losartan—type 2 diabetes mellitus	3.97e-05	0.000383	CcSEcCtD
Guanabenz—Rash—Gliclazide—type 2 diabetes mellitus	3.94e-05	0.00038	CcSEcCtD
Guanabenz—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.00038	CcSEcCtD
Guanabenz—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000379	CcSEcCtD
Guanabenz—Urticaria—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000378	CcSEcCtD
Guanabenz—Shock—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000378	CcSEcCtD
Guanabenz—Headache—Gliclazide—type 2 diabetes mellitus	3.91e-05	0.000378	CcSEcCtD
Guanabenz—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000377	CcSEcCtD
Guanabenz—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000376	CcSEcCtD
Guanabenz—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000376	CcSEcCtD
Guanabenz—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000376	CcSEcCtD
Guanabenz—Tachycardia—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000375	CcSEcCtD
Guanabenz—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.88e-05	0.000375	CcSEcCtD
Guanabenz—Skin disorder—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000373	CcSEcCtD
Guanabenz—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.82e-05	0.000369	CcSEcCtD
Guanabenz—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.79e-05	0.000366	CcSEcCtD
Guanabenz—Dizziness—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000366	CcSEcCtD
Guanabenz—Anorexia—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000366	CcSEcCtD
Guanabenz—Dizziness—Orlistat—type 2 diabetes mellitus	3.75e-05	0.000362	CcSEcCtD
Guanabenz—Asthenia—Metformin—type 2 diabetes mellitus	3.75e-05	0.000362	CcSEcCtD
Guanabenz—Hypotension—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000359	CcSEcCtD
Guanabenz—Nausea—Gliclazide—type 2 diabetes mellitus	3.71e-05	0.000358	CcSEcCtD
Guanabenz—Pruritus—Metformin—type 2 diabetes mellitus	3.69e-05	0.000357	CcSEcCtD
Guanabenz—Urticaria—Losartan—type 2 diabetes mellitus	3.68e-05	0.000356	CcSEcCtD
Guanabenz—Abdominal pain—Losartan—type 2 diabetes mellitus	3.67e-05	0.000354	CcSEcCtD
Guanabenz—Body temperature increased—Losartan—type 2 diabetes mellitus	3.67e-05	0.000354	CcSEcCtD
Guanabenz—Vomiting—Valsartan—type 2 diabetes mellitus	3.65e-05	0.000352	CcSEcCtD
Guanabenz—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000351	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.62e-05	0.00035	CcSEcCtD
Guanabenz—Rash—Valsartan—type 2 diabetes mellitus	3.62e-05	0.000349	CcSEcCtD
Guanabenz—Dermatitis—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000349	CcSEcCtD
Guanabenz—Vomiting—Orlistat—type 2 diabetes mellitus	3.6e-05	0.000348	CcSEcCtD
Guanabenz—Headache—Valsartan—type 2 diabetes mellitus	3.59e-05	0.000347	CcSEcCtD
Guanabenz—Diarrhoea—Metformin—type 2 diabetes mellitus	3.57e-05	0.000345	CcSEcCtD
Guanabenz—Rash—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000345	CcSEcCtD
Guanabenz—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000345	CcSEcCtD
Guanabenz—Dermatitis—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000345	CcSEcCtD
Guanabenz—Headache—Orlistat—type 2 diabetes mellitus	3.55e-05	0.000343	CcSEcCtD
Guanabenz—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000343	CcSEcCtD
Guanabenz—Asthenia—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000342	CcSEcCtD
Guanabenz—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000338	CcSEcCtD
Guanabenz—Pruritus—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000337	CcSEcCtD
Guanabenz—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000334	CcSEcCtD
Guanabenz—Dizziness—Metformin—type 2 diabetes mellitus	3.45e-05	0.000334	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000332	CcSEcCtD
Guanabenz—Fatigue—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000331	CcSEcCtD
Guanabenz—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.42e-05	0.00033	CcSEcCtD
Guanabenz—Nausea—Valsartan—type 2 diabetes mellitus	3.41e-05	0.000329	CcSEcCtD
Guanabenz—Constipation—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000329	CcSEcCtD
Guanabenz—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000326	CcSEcCtD
Guanabenz—Nausea—Orlistat—type 2 diabetes mellitus	3.37e-05	0.000325	CcSEcCtD
Guanabenz—Asthenia—Losartan—type 2 diabetes mellitus	3.33e-05	0.000322	CcSEcCtD
Guanabenz—Vomiting—Metformin—type 2 diabetes mellitus	3.32e-05	0.000321	CcSEcCtD
Guanabenz—Rash—Metformin—type 2 diabetes mellitus	3.29e-05	0.000318	CcSEcCtD
Guanabenz—Dermatitis—Metformin—type 2 diabetes mellitus	3.29e-05	0.000318	CcSEcCtD
Guanabenz—Pruritus—Losartan—type 2 diabetes mellitus	3.28e-05	0.000317	CcSEcCtD
Guanabenz—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000317	CcSEcCtD
Guanabenz—Headache—Metformin—type 2 diabetes mellitus	3.27e-05	0.000316	CcSEcCtD
Guanabenz—Dizziness—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000315	CcSEcCtD
Guanabenz—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000314	CcSEcCtD
Guanabenz—Diarrhoea—Losartan—type 2 diabetes mellitus	3.17e-05	0.000307	CcSEcCtD
Guanabenz—Urticaria—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000305	CcSEcCtD
Guanabenz—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000304	CcSEcCtD
Guanabenz—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000304	CcSEcCtD
Guanabenz—Vomiting—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000303	CcSEcCtD
Guanabenz—Rash—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.0003	CcSEcCtD
Guanabenz—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.0003	CcSEcCtD
Guanabenz—Nausea—Metformin—type 2 diabetes mellitus	3.1e-05	0.0003	CcSEcCtD
Guanabenz—Headache—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.000298	CcSEcCtD
Guanabenz—Dizziness—Losartan—type 2 diabetes mellitus	3.07e-05	0.000296	CcSEcCtD
Guanabenz—Vomiting—Losartan—type 2 diabetes mellitus	2.95e-05	0.000285	CcSEcCtD
Guanabenz—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000283	CcSEcCtD
Guanabenz—Nausea—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000283	CcSEcCtD
Guanabenz—Rash—Losartan—type 2 diabetes mellitus	2.92e-05	0.000283	CcSEcCtD
Guanabenz—Dermatitis—Losartan—type 2 diabetes mellitus	2.92e-05	0.000282	CcSEcCtD
Guanabenz—Headache—Losartan—type 2 diabetes mellitus	2.91e-05	0.000281	CcSEcCtD
Guanabenz—Asthenia—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000276	CcSEcCtD
Guanabenz—Pruritus—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000272	CcSEcCtD
Guanabenz—Nausea—Losartan—type 2 diabetes mellitus	2.75e-05	0.000266	CcSEcCtD
Guanabenz—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000263	CcSEcCtD
Guanabenz—Dizziness—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000254	CcSEcCtD
Guanabenz—Vomiting—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000244	CcSEcCtD
Guanabenz—Rash—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000242	CcSEcCtD
Guanabenz—Dermatitis—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000242	CcSEcCtD
Guanabenz—Headache—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000241	CcSEcCtD
Guanabenz—Nausea—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000228	CcSEcCtD
Guanabenz—ADRA2B—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.1e-06	0.000149	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.08e-06	0.000149	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	5.06e-06	0.000148	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.05e-06	0.000148	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.02e-06	0.000147	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CD36—type 2 diabetes mellitus	5.02e-06	0.000147	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	5e-06	0.000146	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	5e-06	0.000146	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPP2CA—type 2 diabetes mellitus	4.95e-06	0.000145	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOB—type 2 diabetes mellitus	4.95e-06	0.000145	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.93e-06	0.000145	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.93e-06	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—SRC—type 2 diabetes mellitus	4.91e-06	0.000144	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.89e-06	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	4.88e-06	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	4.88e-06	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	4.88e-06	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	4.88e-06	0.000143	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.87e-06	0.000143	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.85e-06	0.000142	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.8e-06	0.000141	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—type 2 diabetes mellitus	4.78e-06	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AVP—type 2 diabetes mellitus	4.78e-06	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.78e-06	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.76e-06	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—type 2 diabetes mellitus	4.75e-06	0.000139	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.74e-06	0.000139	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LPL—type 2 diabetes mellitus	4.73e-06	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GNB3—type 2 diabetes mellitus	4.71e-06	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.71e-06	0.000138	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4.69e-06	0.000138	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.69e-06	0.000137	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HMOX1—type 2 diabetes mellitus	4.69e-06	0.000137	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	4.68e-06	0.000137	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARA—type 2 diabetes mellitus	4.66e-06	0.000137	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.65e-06	0.000136	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.63e-06	0.000136	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.63e-06	0.000136	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAT—type 2 diabetes mellitus	4.63e-06	0.000136	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOB—type 2 diabetes mellitus	4.62e-06	0.000135	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.6e-06	0.000135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.57e-06	0.000134	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	4.57e-06	0.000134	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.55e-06	0.000133	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	4.55e-06	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AGT—type 2 diabetes mellitus	4.52e-06	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.5e-06	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	4.49e-06	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.48e-06	0.000131	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.46e-06	0.000131	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CALM1—type 2 diabetes mellitus	4.44e-06	0.00013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.43e-06	0.00013	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—type 2 diabetes mellitus	4.42e-06	0.00013	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LPL—type 2 diabetes mellitus	4.41e-06	0.000129	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.4e-06	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	4.39e-06	0.000129	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOA1—type 2 diabetes mellitus	4.37e-06	0.000128	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	4.37e-06	0.000128	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.35e-06	0.000128	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.35e-06	0.000128	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.32e-06	0.000127	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	4.29e-06	0.000126	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.28e-06	0.000125	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—C3—type 2 diabetes mellitus	4.25e-06	0.000125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.2e-06	0.000123	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	4.2e-06	0.000123	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.2e-06	0.000123	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	0.000123	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.14e-06	0.000121	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	0.000119	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.07e-06	0.000119	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.06e-06	0.000119	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.06e-06	0.000119	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.05e-06	0.000119	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—type 2 diabetes mellitus	4.04e-06	0.000118	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—type 2 diabetes mellitus	4.02e-06	0.000118	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	0.000118	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.98e-06	0.000117	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.98e-06	0.000117	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.97e-06	0.000116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.97e-06	0.000116	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—C3—type 2 diabetes mellitus	3.97e-06	0.000116	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—type 2 diabetes mellitus	3.96e-06	0.000116	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—type 2 diabetes mellitus	3.96e-06	0.000116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.94e-06	0.000115	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.92e-06	0.000115	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.9e-06	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.88e-06	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.87e-06	0.000113	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-06	0.000113	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.85e-06	0.000113	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—type 2 diabetes mellitus	3.85e-06	0.000113	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.85e-06	0.000113	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.81e-06	0.000112	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.79e-06	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	3.79e-06	0.000111	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.79e-06	0.000111	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.78e-06	0.000111	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—type 2 diabetes mellitus	3.78e-06	0.000111	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—type 2 diabetes mellitus	3.78e-06	0.000111	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—type 2 diabetes mellitus	3.76e-06	0.00011	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	3.75e-06	0.00011	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.74e-06	0.00011	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.74e-06	0.00011	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.74e-06	0.000109	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.71e-06	0.000109	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—type 2 diabetes mellitus	3.7e-06	0.000108	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—type 2 diabetes mellitus	3.7e-06	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.7e-06	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	3.67e-06	0.000107	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.66e-06	0.000107	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	3.61e-06	0.000106	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	0.000105	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.59e-06	0.000105	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	0.000104	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.53e-06	0.000104	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.51e-06	0.000103	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.49e-06	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.49e-06	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.48e-06	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.48e-06	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.48e-06	0.000102	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	3.47e-06	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.41e-06	0.0001	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.38e-06	9.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	3.38e-06	9.92e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.36e-06	9.86e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.34e-06	9.78e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.33e-06	9.76e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	3.32e-06	9.71e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	3.32e-06	9.71e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.31e-06	9.7e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.3e-06	9.68e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.3e-06	9.67e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.27e-06	9.59e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.27e-06	9.58e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.26e-06	9.54e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	3.23e-06	9.46e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.18e-06	9.32e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.16e-06	9.26e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.15e-06	9.22e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	9.17e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.11e-06	9.11e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.11e-06	9.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.08e-06	9.02e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.07e-06	9e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	9e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.07e-06	8.99e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.07e-06	8.99e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.06e-06	8.96e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.06e-06	8.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	3.05e-06	8.95e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.05e-06	8.94e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.04e-06	8.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	3.03e-06	8.88e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.02e-06	8.84e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.02e-06	8.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.02e-06	8.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.01e-06	8.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.01e-06	8.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.97e-06	8.71e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.97e-06	8.7e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.97e-06	8.7e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.9e-06	8.51e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.83e-06	8.3e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	2.81e-06	8.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.79e-06	8.18e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.77e-06	8.12e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.77e-06	8.12e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	7.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	7.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.68e-06	7.86e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.61e-06	7.65e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.6e-06	7.62e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.6e-06	7.62e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.59e-06	7.58e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.57e-06	7.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.55e-06	7.48e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.54e-06	7.45e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.53e-06	7.4e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.52e-06	7.38e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.5e-06	7.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.48e-06	7.28e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.48e-06	7.27e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.48e-06	7.26e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.47e-06	7.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	7.22e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.41e-06	7.07e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.38e-06	6.98e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.38e-06	6.96e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.37e-06	6.94e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.36e-06	6.91e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.36e-06	6.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.35e-06	6.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.34e-06	6.85e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.32e-06	6.79e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.31e-06	6.77e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.31e-06	6.77e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.25e-06	6.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.25e-06	6.6e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.25e-06	6.59e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.22e-06	6.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.22e-06	6.51e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.2e-06	6.45e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.2e-06	6.43e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.16e-06	6.32e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.14e-06	6.26e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.13e-06	6.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.12e-06	6.21e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.09e-06	6.13e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.05e-06	6.01e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.02e-06	5.93e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2e-06	5.85e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.99e-06	5.83e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.98e-06	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.96e-06	5.75e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.96e-06	5.75e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.93e-06	5.65e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.92e-06	5.64e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.91e-06	5.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.9e-06	5.56e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.83e-06	5.37e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.81e-06	5.29e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.8e-06	5.27e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.79e-06	5.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.75e-06	5.13e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.73e-06	5.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	4.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.67e-06	4.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.62e-06	4.75e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	4.55e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	4.47e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.49e-06	4.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.49e-06	4.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.49e-06	4.36e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.48e-06	4.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.46e-06	4.28e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.38e-06	4.05e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.36e-06	4e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	3.98e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.27e-06	3.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	3.29e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.03e-06	3.03e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.83e-07	2e-05	CbGpPWpGaD
